Transplant Drugs Flashcards

1
Q

What are the 3 drugs of triple maintenance therapy? (name drug type not specifics)

A
  1. Anti-metabolite.
  2. Calcineurin Inhibitor
  3. Prednisone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the main anti-metabolite drug used w/ triple therapy?

A

mycophenolate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the main calcineurin Inhibitor drug used w/ triple therapy?

A

tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Is Azathioprine a prodrug?

A

yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does azathioprine get converted into?

A

6 MP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of azathioprine

A

decrease B and T lymphocytes, decrease IG synthesis, decrease IL-2 secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens if you have a generic alteration of TPMT?

A

you can’t degrade 6MP causing increased immunosuppression (pt would need lower aza dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what often blocks XO in the azathioprine/6MP pathway?

A

gout medications, causing increased concentration of 6MP and increased immunosupression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what allele for azathioprine requires dose reduction?

A

heterozygous for non-functional allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what allele type can you not give azathioprine?

A

homozygous for non-functional allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what drugs should be avoided w/ azathioprine use?

A

ACEI
allopurinol/febuxostat
Aminosalicylates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what happens if you give ACEI + Azathioprine?

A

anemia

severe leukopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what happens if you give Allopurional/febuxo + azathiroprine?

A

inhibition of XO leads to increase myelosuppression risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens if you give aminosalicylates + azathioprine?

A

inhibition of TPMT leads to increase myelosuppression risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADR of azathioprine?

A
N/V
Hepatotoxic
Pancreatitis
Myelosupression (bac & viral)
Malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what cancer are azathioprine pts @ risk for?

A

Skin SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what pts have increase risk of malignant dz?

A

renal transplant pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mechanism of Mycophenolate

A

decrease B & T cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

indications of Mycophenolate use

A

transplants
auto-immune dz pts
GVHD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what can decrease absorption of mycophenolate?

A

Fe
antacids
cholestyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

if you decrease the absorption of mycophenolate what happens?

A

increased risk of REJECTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ADR of mycophenolate

A

N/V/D/abd cramp
myelosuppression
miscarriage & birth defects

23
Q

Cyclosporine MOA

A

decrease production/release of IL-1 and inhibits IL-2 induced activation of resting T lymphocytes

24
Q

indications for cyclosporine

A

transplant
auto-immune dz: RA, psoriasis, IBD
ophthalmic emulsion

25
what ophthalmic condition does cyclosporine tx?
keratoconjunctivitis sicca-associated ocular inflammation (aka helps increase tear production)
26
drug interactions of cyclosporine?
*nephrotox with other nephrotoxic drugs (gentamicin) | pGp & 3A4 substrate (also inhibits 3A4)
27
ADR of cyclosporine?
``` nephrotoxic--AKI (most significant ADR) HTN neurotoxic PTDM Increase lipids & uric acid myelosuppression gingival` hyperplasia hirsutism N/V/D ```
28
Tacrolimus stands for what?
tsukuba macrolide immunosupressant
29
MOA of tacrolimus
binds to immunophillin to modulate T cells
30
indications of tacrolimus PO
transplant | ulcerative colitis
31
indications of tacrolimus topical
mod/severe atopic dermatitis
32
drugs interactions of tacrolimus?
*nephrotox with other nephrotoxic drugs (gentamicin) | pGp & 3A4 substrate (also inhibits 3A4)
33
ADR of tacrolimus
similar to cyclosporine
34
what ADR occurs more with tacrolimus vs cyclosporine?
PTDM
35
what ADR occurs less with tacrolimus vs cyclosprine?
every other ADR is less w/ tacrolimus
36
what is prednisone converted to?
predisolone
37
drug interactions of prednisone?
antagonistes anti DM meds
38
ADRS of acute use of prednisone
insomnia nervousness increase appetite hyperglycemia
39
ADRs of chronic use of prednisone
``` hirsutism cataract fat redistribution* fluid retention osteoporosis/AVN* poor would healing HPA-axis suppression/growth impression* myopathy *= M/C ADR ```
40
what type of myopathy do pts taking prednisone get?
proxmial muscle weakness w/o myalgis or tenderness
41
what part of the body gets weakness 1st?
LE
42
how severe is the muscle weakness associated with prednisone?
affects ADLs
43
what dose makes the myopathy of prednisone uncommon?
<10mg/d
44
what dose makes myopathies of prednisone v' common?
>40mg-60mg/d for more than 1 month
45
what kind of a drug is sirolimus/rapamycin?
MTOR inhibitor
46
MOA of sirolimus/rapamycin
inhibit MTOR to then suppress cytokine driven T cell proliferation
47
what can siroliumus replace in triple therapy?
anti-metabolite or calcineurin inhibitor
48
main thing to monitor w/ sirolimus/rapamycin
BP
49
drug interactions of sirolimus/rapamycin
Cyp3A4 substrate and pgp
50
ADR of sirolimus/rapamycin
``` HA tremor HTN edema PTDM renal dysfunction ```
51
MOA of belatacept
T cell costimulation blocker | inhibits production of cytokines
52
use of belatacept
renal transplant in pts who are EBV serotype +
53
ADR of belatacept
``` leukopenia anemia N/V/D increase malignancy risk PT lymphoproliferative disorder (PTLD) ```